124 related articles for article (PubMed ID: 33886292)
1. New Thyrointegrin α
Hay BA; Godugu K; Darwish NHE; Fujioka K; Sudha T; Karakus OO; Mousa SA
J Med Chem; 2021 May; 64(9):6300-6309. PubMed ID: 33886292
[TBL] [Abstract][Full Text] [Related]
2. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
[TBL] [Abstract][Full Text] [Related]
3. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
[TBL] [Abstract][Full Text] [Related]
4. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.
Darwish NHE; Glinsky GV; Sudha T; Mousa SA
Front Oncol; 2021; 11():793810. PubMed ID: 35155195
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme.
Godugu K; Hay BA; Glinsky GV; Mousa SA
Neurooncol Adv; 2023; 5(1):vdac180. PubMed ID: 36879662
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α
Fujioka K; Hay BA; Godugu K; Mousa SA
Front Pharmacol; 2022; 13():902141. PubMed ID: 36518666
[TBL] [Abstract][Full Text] [Related]
7. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
[TBL] [Abstract][Full Text] [Related]
9. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
11. β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate.
López Rivas P; Müller C; Breunig C; Hechler T; Pahl A; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
Org Biomol Chem; 2019 May; 17(19):4705-4710. PubMed ID: 31020985
[TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma.
Karakus OO; Godugu K; Rajabi M; Mousa SA
J Med Chem; 2020 Jul; 63(14):7653-7662. PubMed ID: 32571015
[TBL] [Abstract][Full Text] [Related]
13. Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.
Glinsky GV; Godugu K; Sudha T; Rajabi M; Chittur SV; Hercbergs AA; Mousa SA; Davis PJ
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448512
[TBL] [Abstract][Full Text] [Related]
14. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α
Sudha T; Godugu K; Glinsky GV; Mousa SA
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453545
[TBL] [Abstract][Full Text] [Related]
15. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
16. An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression.
Shan X; Zhang L; Xu Y; Sun L; Guo L; Feng S; Ge H; Gu T; Ning X
Chem Commun (Camb); 2020 Feb; 56(14):2178-2181. PubMed ID: 31971174
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Elkamhawy A; Viswanath AN; Pae AN; Kim HY; Heo JC; Park WK; Lee CO; Yang H; Kim KH; Nam DH; Seol HJ; Cho H; Roh EJ
Eur J Med Chem; 2015 Oct; 103():210-22. PubMed ID: 26355532
[TBL] [Abstract][Full Text] [Related]
18. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
Li M; Liang Z; Sun X; Gong T; Zhang Z
PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
[TBL] [Abstract][Full Text] [Related]
19. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
[TBL] [Abstract][Full Text] [Related]
20. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
